Literature DB >> 24352645

Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family.

Fengju Song1, Da Yang, Ben Liu, Yan Guo, Hong Zheng, Lian Li, Tao Wang, Jinpu Yu, Yanrui Zhao, Ruifang Niu, Han Liang, Hans Winkler, Wei Zhang, Xishan Hao, Kexin Chen.   

Abstract

PURPOSE: Our aim was to investigate whether microRNAs can predict the clinical outcome of patients with gastric cancer. We used integrated analysis of microRNA and mRNA expression profiles to identify gastric cancer microRNA subtypes and their underlying regulatory scenarios. EXPERIMENTAL
DESIGN: MicroRNA-based gastric cancer subtypes were identified by consensus clustering analysis of microRNA profiles of 90 gastric cancer tissues. Activated pathways in the subtypes were identified by gene expression profiles. Further integrated analysis was conducted to model a microRNA regulatory network for each subtype. RNA and protein expression were analyzed by RT-PCR and tissue microarray, respectively, in a cohort of 385 gastric cancer cases (including the 90 cases for profiling) to validate the key microRNAs and targets in the network. Both in vitro and in vivo experiments were carried out to further validate the findings.
RESULTS: MicroRNA profiles of 90 gastric cancer cases identified two microRNA subtypes significantly associated with survival. The poor-prognosis gastric cancer microRNA subtype was characterized by overexpression of epithelial-to-mesenchymal transition (EMT) markers. This gastric cancer "mesenchymal subtype" was further validated in a patient cohort comprising 385 cases. Integrated analysis identified a key microRNA regulatory network likely driving the gastric cancer mesenchymal subtype. Three of the microRNAs (miR-200c, miR-200b, and miR-125b) targeting the most genes in the network were significantly associated with survival. Functional experiments demonstrated that miR-200b suppressed ZEB1, augmented E-cadherin, inhibited cell migration, and suppressed tumor growth in a mouse model.
CONCLUSIONS: We have uncovered a key microRNA regulatory network that defines the mesenchymal gastric cancer subtype significantly associated with poor overall survival in gastric cancer. ©2013 AACR

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24352645     DOI: 10.1158/1078-0432.CCR-13-1844

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  51 in total

Review 1.  Interaction between gastric cancer stem cells and the tumor microenvironment.

Authors:  Takatsugu Ishimoto; Hiroshi Sawayama; Hidetaka Sugihara; Hideo Baba
Journal:  J Gastroenterol       Date:  2014-03-21       Impact factor: 7.527

2.  Prognostic role of miR-200c in various malignancies: a systematic review and meta-analysis.

Authors:  Ke-Cheng Zhang; Hong-Qing Xi; Jian-Xin Cui; Wei-Song Shen; Ji-Yang Li; Bo Wei; Lin Chen
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  MiR-548a-3p Promotes Keratinocyte Proliferation Targeting PPP3R1 after Being Induced by IL-22.

Authors:  Xintong Zhao; Ronghua Li; Meng Qiao; Jianjun Yan; Qing Sun
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

4.  MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression.

Authors:  Ruixin Li; Weijie Yuan; Wenjuan Mei; Keda Yang; Zihua Chen
Journal:  Mol Cell Biochem       Date:  2014-07-26       Impact factor: 3.396

5.  Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.

Authors:  Kexin Chen; Da Yang; Xiangchun Li; Baocun Sun; Fengju Song; Wenfeng Cao; Daniel J Brat; Zhibo Gao; Haixin Li; Han Liang; Yanrui Zhao; Hong Zheng; Miao Li; Jan Buckner; Scott D Patterson; Xiang Ye; Christoph Reinhard; Anahita Bhathena; Deepa Joshi; Paul S Mischel; Carlo M Croce; Yi Michael Wang; Sreekumar Raghavakaimal; Hui Li; Xin Lu; Yang Pan; Han Chang; Sujuan Ba; Longhai Luo; Webster K Cavenee; Wei Zhang; Xishan Hao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

6.  Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns.

Authors:  Amanda L Treece; Daniel L Duncan; Weihua Tang; Sandra Elmore; Douglas R Morgan; Ricardo L Dominguez; Olga Speck; Michael O Meyers; Margaret L Gulley
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

7.  Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.

Authors:  Songyang Wu; Hao Liu; Heng Zhang; Chao Lin; Ruochen Li; Yifan Cao; Hongyong He; He Li; Zhenbin Shen; Jing Qin; Jiejie Xu
Journal:  Tumour Biol       Date:  2016-07-21

8.  Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory Drugs.

Authors:  Ruixia Ma; Bin Yi; Gary A Piazza; Yaguang Xi
Journal:  Curr Pharmacol Rep       Date:  2015-06-01

9.  MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1.

Authors:  Jiang Yan; Xiaoqiang Guo; Jiazeng Xia; Tin Shan; Chen Gu; Zheng Liang; Wei Zhao; Shimao Jin
Journal:  Med Oncol       Date:  2014-02-11       Impact factor: 3.064

10.  MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1.

Authors:  Shuai Chang; Shicai He; Guanglin Qiu; Jing Lu; Jin Wang; Junsong Liu; Lin Fan; Wei Zhao; Xiangming Che
Journal:  Tumour Biol       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.